OR WAIT null SECS
May 11, 2022
The importance of equitable approaches to diagnosis and treatment.
With lessons and perspectives from the field, the importance of harnessing the right combination of skills to advance up and across career ladders is explored.
May 03, 2022
Hill shares her insights on what is needed for a turnaround in talent development.
April 21, 2022
New C-Suite position emerges for more emphasis on patient centricity.
April 11, 2022
With an increase in drug development, why purpose should be the pharma industry’s secret advantage in the global talent shortage, as the COVID-19 crisis transitions into the endemic stage.
Reshma Kewalramani, MD, FASN, chief executive officer and president of Vertex Pharmaceuticals talks about how she supports the efforts of DE&I within and outside her organization.
Robert McMahon, former president of Merck US Human Health, shares some of the challenges leaders face when grappling with how to transform their organizations to embrace DE&I.
Benchmark study across healthcare sectors measures progress in advancing women and people of color into top leadership roles.
Why their influence on employee representation matters for pharma.
March 23, 2022
It takes flexibility and adaptability to switch a company’s focus. Here, Alkermes’ Chief Operating Officer Blair Jackson discusses how his team pivoted from developing CNS to oncology therapies and the skills it required.
